Inhibition of miRNA-223-3p led to a significant increase in NLRP3 mRNA at 2 and 4 days p.i., thus confirming that NLRP3 was a target of miRNA-223-3p during SARS-CoV infection (Fig. 6). Here, NLRP3 is linked to severe acute respiratory syndrome.